Eli Lilly takes weight-loss pill battle global with first Foundayo approval in Europe

Eli Lilly's Foundayo weight-loss pill has won approval in the United Kingdom, CNBC reports, marking the drug's first authorization outside the United States. The approval brings Foundayo's competition with Novo Nordisk's Wegovy to international markets.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton